| Melissa Ann Saftner, CNM | |
|
606 24th Ave S Ste 300, Minneapolis, MN 55454-1437 | |
| (612) 273-7111 | |
| Not Available |
| Full Name | Melissa Ann Saftner |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 15 Years |
| Location | 606 24th Ave S Ste 300, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093948374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | CNM41 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
News Archive
The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).
The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients with early symptomatic osteoarthritis of the knee avoid performing normal daily physical activities because they are experiencing pain, findings of a large, longitudinal study suggest.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
› Verified 5 days ago
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).
The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients with early symptomatic osteoarthritis of the knee avoid performing normal daily physical activities because they are experiencing pain, findings of a large, longitudinal study suggest.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
› Verified 5 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).
The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients with early symptomatic osteoarthritis of the knee avoid performing normal daily physical activities because they are experiencing pain, findings of a large, longitudinal study suggest.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
› Verified 5 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).
The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients with early symptomatic osteoarthritis of the knee avoid performing normal daily physical activities because they are experiencing pain, findings of a large, longitudinal study suggest.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
› Verified 5 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).
The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients with early symptomatic osteoarthritis of the knee avoid performing normal daily physical activities because they are experiencing pain, findings of a large, longitudinal study suggest.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Ann Saftner, CNM 606 24th Ave S Ste 300, Minneapolis, MN 55454-1437 Ph: (612) 273-7111 | Melissa Ann Saftner, CNM 606 24th Ave S Ste 300, Minneapolis, MN 55454-1437 Ph: (612) 273-7111 |
News Archive
The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).
The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
Patients with early symptomatic osteoarthritis of the knee avoid performing normal daily physical activities because they are experiencing pain, findings of a large, longitudinal study suggest.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
› Verified 5 days ago
Claire C Nelson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 | |
Pamela S.f. Glenn, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1200 Lagoon Ave, Minneapolis, MN 55408 Phone: 612-823-6300 | |
Susanna Goldstein, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3033 Excelsior Blvd, Minneapolis, MN 55416 Phone: 612-345-5920 | |
Heather Christopher, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2606 Chicago Ave, Minneapolis, MN 55407 Phone: 612-545-5311 | |
Olivia Lynn Fricke, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1919 Nicollet Ave, Minneapolis, MN 55403 Phone: 719-580-9134 Fax: 612-236-4745 | |
Julia M Cross, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 | |
Nancy L Schamber, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 |